BERLIN — The German government is taking a 23% stake in a German company working on a potential vaccine for the coronavirus.
Economy Minister Peter Altmaier said Monday that the state-owned KfW development bank will buy 300 million euros ($337 million) in CureVac shares. He said the aim is to give CureVac “financial security.”
Altmaier stressed the government’s desire to keep key companies in various sectors in Germany.
In March, Chancellor Angela Merkel’s chief of staff, Helge Braun, said that German officials had had “very intensive contact” with Curevac and that there had been “thoughts of enticing it to the United States.” He didn’t elaborate on the nature of the U.S. interest.
LONDON (AP) — A mammoth three-year public inquiry into the U.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.06 USD
